檢索結果 - Jonathan C. Trent

Refine Results
  1. 1
    Adjuvant and neoadjuvant imatinib therapy: Current role in the management of gastrointestinal stromal tumors

    Adjuvant and neoadjuvant imatinib therapy: Current role in the management of gastrointestinal stromal tumors 由 Burton Eisenberg, Jonathan C. Trent

    出版 2011
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  2. 2
    The favorable impact of PIK3CA mutations on survival: an analysis of 2587 patients with breast cancer

    The favorable impact of PIK3CA mutations on survival: an analysis of 2587 patients with breast cancer 由 Amaury G. Dumont, Sarah Dumont, Jonathan C. Trent

    出版 2012
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  3. 3
    Update on the Biology and Therapy of Gastrointestinal Stromal Tumors

    Update on the Biology and Therapy of Gastrointestinal Stromal Tumors 由 Gina Z. D’Amato, Dejka M. Steinert, John C. McAuliffe, Jonathan C. Trent

    出版 2005
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  4. 4
    Response of Histiocytoses to Imatinib Mesylate: Fire to Ashes

    Response of Histiocytoses to Imatinib Mesylate: Fire to Ashes 由 Filip Janků, Hesham M. Amin, Dan Yang, Ignacio Garrido‐Laguna, Jonathan C. Trent, Razelle Kurzrock

    出版 2010
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Targeting the Apoptotic Pathway in Chondrosarcoma Using Recombinant Human Apo2L/TRAIL (Dulanermin), a Dual Proapoptotic Receptor (DR4/DR5) Agonist

    Targeting the Apoptotic Pathway in Chondrosarcoma Using Recombinant Human Apo2L/TRAIL (Dulanermin), a Dual Proapoptotic Receptor (DR4/DR5) Agonist 由 Vivek Subbiah, Robert Brown, Jamie Buryanek, Jonathan C. Trent, Avi Ashkenazi, Roy S. Herbst, Razelle Kurzrock

    出版 2012
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Utility of Circulating Tumor DNA in the Management of Patients With GI Stromal Tumor: Analysis of 243 Patients

    Utility of Circulating Tumor DNA in the Management of Patients With GI Stromal Tumor: Analysis of 243 Patients 由 Junaid Arshad, Ali Roberts, Jibran Ahmed, Jared Addison Cotta, Brian Pico, Deukoo Kwon, Jonathan C. Trent

    出版 2020
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    A two‐arm phase II study of temozolomide in patients with advanced gastrointestinal stromal tumors and other soft tissue sarcomas

    A two‐arm phase II study of temozolomide in patients with advanced gastrointestinal stromal tumors and other soft tissue sarcomas 由 Jonathan C. Trent, Jennifer Beach, M. A. Burgess, Nicholas Papadopolous, Lei L. Chen, Robert S. Benjamin, Shreyaskumar Patel

    出版 2003
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Resection of pulmonary metastases in pediatric patients with Ewing sarcoma improves survival

    Resection of pulmonary metastases in pediatric patients with Ewing sarcoma improves survival 由 Phillip A. Letourneau, Brett Shackett, Lianchun Xiao, Jonathan C. Trent, KuoJen Tsao, Kevin P. Lally, Andrea Hayes‐Jordan

    出版 2011
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    BRAF Mutant Gastrointestinal Stromal Tumor: First report of regression with BRAF inhibitor dabrafenib (GSK2118436) and whole exomic sequencing for analysis of acquired resistance

    BRAF Mutant Gastrointestinal Stromal Tumor: First report of regression with BRAF inhibitor dabrafenib (GSK2118436) and whole exomic sequencing for analysis of acquired resistance 由 Gerald S. Falchook, Jonathan C. Trent, Michael C. Heinrich, Carol Beadling, J. W. Patterson, Christel C. Bastida, S Blackman, Razelle Kurzrock

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including <i>VEGFA</i>, in human osteosarcoma

    Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including <i>VEGFA</i>, in human osteosarcoma 由 Jilong Yang, Da Yang, Yan Sun, Baocun Sun, Guowen Wang, Jonathan C. Trent, Dejka M. Araujo, Kexin Chen, Wei Zhang

    出版 2011
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Gastrointestinal Stromal Tumors: The GIST of Precision Medicine

    Gastrointestinal Stromal Tumors: The GIST of Precision Medicine 由 Lin Mei, Steven C. Smith, Anthony C. Faber, Jonathan C. Trent, Steven R. Grossman, Constantine A. Stratakis, Sosipatros A. Boikos

    出版 2017
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  12. 12
    Genomic and Molecular Characterization of Malignant Peripheral Nerve Sheath Tumor Identifies the IGF1R Pathway as a Primary Target for Treatment

    Genomic and Molecular Characterization of Malignant Peripheral Nerve Sheath Tumor Identifies the IGF1R Pathway as a Primary Target for Treatment 由 Jilong Yang, Antti Ylipää, Yan Sun, Hong Zheng, Kexin Chen, Matti Nykter, Jonathan C. Trent, Nancy Ratner, Dina Lev, Wei Zhang

    出版 2011
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Cardiac Tumors in a Tertiary Care Cancer Hospital: Clinical Features, Echocardiographic Findings, Treatment and Outcomes

    Cardiac Tumors in a Tertiary Care Cancer Hospital: Clinical Features, Echocardiographic Findings, Treatment and Outcomes 由 Syed Wamique Yusuf, Jaya Bathina, S. Qureshi, Husnu E. Kaynak, José Banchs, Jonathan C. Trent, Vinod Ravi, Iyad N. Daher, Joseph Swafford

    出版 2012
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Genetic aberrations of gastrointestinal stromal tumors

    Genetic aberrations of gastrointestinal stromal tumors 由 Jilong Yang, Xiaoling Du, Alexander J. Lazar, Raphael E. Pollock, Kelly K. Hunt, Kexin Chen, Xishan Hao, Jonathan C. Trent, Wei Zhang

    出版 2008
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  15. 15
    Dasatinib Inhibits Migration and Invasion in Diverse Human Sarcoma Cell Lines and Induces Apoptosis in Bone Sarcoma Cells Dependent on Src Kinase for Survival

    Dasatinib Inhibits Migration and Invasion in Diverse Human Sarcoma Cell Lines and Induces Apoptosis in Bone Sarcoma Cells Dependent on Src Kinase for Survival 由 Audrey C. Shor, Elizabeth A. Keschman, Francis Y. Lee, Carlos Muro‐Cacho, G. Douglas Letson, Jonathan C. Trent, W. J. Pledger, Richard Jove

    出版 2007
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Expression of receptor tyrosine kinases epidermal growth factor receptor and HER‐2/<i>neu</i> in synovial sarcoma

    Expression of receptor tyrosine kinases epidermal growth factor receptor and HER‐2/<i>neu</i> in synovial sarcoma 由 Dafydd G. Thomas, Thomas J. Giordano, Donita Sanders, Sybil J. Biermann, Vernon K. Sondak, Jonathan C. Trent, Dihua Yu, Raphael E. Pollock, Laurence Baker

    出版 2005
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Primary angiosarcomas of the breast

    Primary angiosarcomas of the breast 由 Taimur Sher, Bryan T. Hennessy, Vicente Valero, K. Broglio, Wendy A. Woodward, Jonathan C. Trent, Kelly K. Hunt, Gabriel N. Hortobágyi, Ana M. Gonzalez‐Angulo

    出版 2007
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    Survival of patients with multiple primary malignancies: a study of 783 patients with gastrointestinal stromal tumor

    Survival of patients with multiple primary malignancies: a study of 783 patients with gastrointestinal stromal tumor 由 Renganayaki Pandurengan, Agathe Dumont, Dejka M. Araujo, Joseph A. Ludwig, Vinod Ravi, Shreyaskumar Patel, Judy E. Garber, Robert S. Benjamin, Sanna Ström, Jonathan C. Trent

    出版 2010
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondrosarcoma Cells

    Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondrosarcoma Cell... 由 Luyuan Li, Ana C. Paz, Breelyn A. Wilky, Britt Johnson, Karina Galoian, Andrew E. Rosenberg, Guozhi Hu, Gabriel Tinoco, Olaf Bodamer, Jonathan C. Trent

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    Efficacy and Tolerability of 5-Year Adjuvant Imatinib Treatment for Patients With Resected Intermediate- or High-Risk Primary Gastrointestinal Stromal Tumor

    Efficacy and Tolerability of 5-Year Adjuvant Imatinib Treatment for Patients With Resected Intermediate- or High-Risk Primary Gastrointestinal Stromal Tumor 由 Chandrajit P. Raut, N. Joseph Espat, Robert G. Maki, Dejka M. Araujo, Jonathan C. Trent, Toni Faith Williams, Das Purkayastha, Ronald P. DeMatteo

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: